News - Page 205 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Mind Cure Announces Addition of Global Technology Leader Robert C. Hill to Board of Directors

Mind Cure Announces Addition of Global Technology Leader Robert C. Hill to Board of Directors

Post published:February 22, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Announces Ethics Approval for In Vivo DMT Study

Entheon Biomedical Announces Ethics Approval for In Vivo DMT Study

Post published:February 22, 2021
Post category:Press Release

Read more about the article Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Post published:February 22, 2021
Post category:Press Release

Read more about the article PsyBio Completes Reverse Take-Over Transaction

PsyBio Completes Reverse Take-Over Transaction

Post published:February 19, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: California Bill Aims to Decriminalize Psychedelics; MindMed Acquires HealthMode; and more…

Psychedelic Bulletin: California Bill Aims to Decriminalize Psychedelics; MindMed Acquires HealthMode; and more…

Post published:February 19, 2021
Post category:Psychedelic Bulletin

Read more about the article Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke Program

Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke Program

Post published:February 19, 2021
Post category:Press Release

Read more about the article Silo Pharma Licenses Novel Peptide-Guided Drug Delivery Approach for the Treatment of MS

Silo Pharma Licenses Novel Peptide-Guided Drug Delivery Approach for the Treatment of MS

Post published:February 18, 2021
Post category:Press Release

Read more about the article Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device

Lobe Sciences Successfully Completes Proof-of-Concept of Proprietary Nasal Mist Device

Post published:February 18, 2021
Post category:Press Release

Read more about the article Red Light Holland Receives Receipt for Final Short-form Prospectus for Previously Announced $10 Million Bought Deal Public Offering

Red Light Holland Receives Receipt for Final Short-form Prospectus for Previously Announced $10 Million Bought Deal Public Offering

Post published:February 18, 2021
Post category:Press Release

Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in collaboration with MAPS Public Benefit Corporation

Post published:February 18, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.